CA1169775A - Composition pharmaceutique notamment a action anti- ischemique - Google Patents

Composition pharmaceutique notamment a action anti- ischemique

Info

Publication number
CA1169775A
CA1169775A CA000386938A CA386938A CA1169775A CA 1169775 A CA1169775 A CA 1169775A CA 000386938 A CA000386938 A CA 000386938A CA 386938 A CA386938 A CA 386938A CA 1169775 A CA1169775 A CA 1169775A
Authority
CA
Canada
Prior art keywords
benzyl
piperazine
day
trimethoxy
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000386938A
Other languages
English (en)
French (fr)
Inventor
Jean-Claude Arnaud
Michelle Devissaguet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9246419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1169775(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Science Union et Cie filed Critical Science Union et Cie
Application granted granted Critical
Publication of CA1169775A publication Critical patent/CA1169775A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000386938A 1980-09-30 1981-09-29 Composition pharmaceutique notamment a action anti- ischemique Expired CA1169775A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR80.20919 1980-09-30
FR8020919A FR2490963B1 (fr) 1980-09-30 1980-09-30 Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine

Publications (1)

Publication Number Publication Date
CA1169775A true CA1169775A (fr) 1984-06-26

Family

ID=9246419

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000386938A Expired CA1169775A (fr) 1980-09-30 1981-09-29 Composition pharmaceutique notamment a action anti- ischemique

Country Status (14)

Country Link
US (1) US4407801A (cg-RX-API-DMAC7.html)
AU (1) AU550761B2 (cg-RX-API-DMAC7.html)
BE (1) BE890568A (cg-RX-API-DMAC7.html)
CA (1) CA1169775A (cg-RX-API-DMAC7.html)
CH (1) CH650675A5 (cg-RX-API-DMAC7.html)
DE (1) DE3139005A1 (cg-RX-API-DMAC7.html)
FR (1) FR2490963B1 (cg-RX-API-DMAC7.html)
GB (1) GB2084019B (cg-RX-API-DMAC7.html)
GR (1) GR75803B (cg-RX-API-DMAC7.html)
IE (1) IE51764B1 (cg-RX-API-DMAC7.html)
IT (1) IT1171557B (cg-RX-API-DMAC7.html)
LU (1) LU83654A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ198435A (cg-RX-API-DMAC7.html)
ZA (1) ZA816766B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448776A (en) * 1981-02-12 1984-05-15 Karl Bucher Method of using certain substituted aliphatic secondary amines or their salts for easing breathing
SE8403912D0 (sv) * 1984-07-30 1984-07-30 Pharmacia Ab Lekemedelssats eller -komposition
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
FR2805463B1 (fr) * 2000-02-25 2003-01-24 Adir UTILISATION DE LA TRIMETAZIDINE POUR L'OBTENTION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES A INHIBER L'ACYL-CoA ACETYLTRANSFERASE
FR2818549B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine
WO2007116243A2 (en) * 2006-04-10 2007-10-18 Mintails Limited Method for treating fibromyalgia and related conditions
EA009776B1 (ru) * 2006-07-18 2008-04-28 Мераб Ревазович Кокеладзе Способ изготовления таблетированной лекарственной формы триметазидина дигидрохлорида и ее состав
FR2986431B1 (fr) * 2012-02-03 2017-03-17 Servier Lab Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
CN105055352A (zh) * 2015-08-11 2015-11-18 瑞阳制药有限公司 盐酸曲美他嗪片及其制备方法
US11123345B2 (en) * 2016-11-21 2021-09-21 Saghmos Therapeutics, Inc. Prevention and/or treatment of contrast-induced acute kidney injury
CN107982231B (zh) * 2018-01-03 2021-05-07 江苏吴中医药集团有限公司 一种盐酸曲美他嗪片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262852A (en) * 1966-07-26 Vasodilator and anti-anginose com- pounds containing methoxy benzyl piperazines and method of using the same
FR805M (cg-RX-API-DMAC7.html) * 1960-06-30 1961-09-01

Also Published As

Publication number Publication date
CH650675A5 (fr) 1985-08-15
IT8149377A1 (it) 1983-03-28
FR2490963A1 (fr) 1982-04-02
BE890568A (fr) 1982-03-30
GB2084019B (en) 1984-09-12
IE812256L (en) 1982-03-30
IE51764B1 (en) 1987-03-18
IT1171557B (it) 1987-06-10
GB2084019A (en) 1982-04-07
ZA816766B (en) 1982-09-29
DE3139005A1 (de) 1982-05-06
FR2490963B1 (fr) 1986-04-18
IT8149377A0 (it) 1981-09-28
AU7574481A (en) 1982-04-08
LU83654A1 (fr) 1982-04-14
AU550761B2 (en) 1986-04-10
GR75803B (cg-RX-API-DMAC7.html) 1984-08-02
US4407801A (en) 1983-10-04
NZ198435A (en) 1984-02-03

Similar Documents

Publication Publication Date Title
CA1169775A (fr) Composition pharmaceutique notamment a action anti- ischemique
RU2324482C2 (ru) Комбинация органических соединений
HU229048B1 (hu) 1-Fenil-3-dimetil-amino-propán-vegyületek gyógyászati sói
CA2979049A1 (en) Lsd for the treatment of alzheimer's disease
KR20250079059A (ko) 모발 성장 자극을 위한 알파-케토부티레이트, 알파-케토글루타레이트, 및 2-하이드록시부티레이트
LT3119B (en) Pharmaceutical composition and process for the preparation thereof
TW202228682A (zh) 使用右美托咪啶(dexmedetomidine)鹽酸鹽治療躁鬱症及精神病
JPH05194209A (ja) 血管内皮細胞機能改善剤
CH683966A5 (it) Composti della classe dei ftalidrazidici come sostanze attive in agenti anti-ipossici e di difesa.
ES2689042T3 (es) Uso de 3-n-butil isoindolina cetona en la preparación de fármacos para prevenir y tratar el infarto cerebral
EP2877170B1 (en) Induction of arteriogenesis with nitroglycerine
CN109069450A (zh) 神经障碍的新的组合疗法
Hayes et al. Preserved Left Ventricular Function despite Myocardial Fibrosis and Myopathy in the Dystrophin‐Deficient D2. B10‐Dmdmdx/J Mouse
JP2003267890A (ja) 不整脈および発作の治療または防止における５−ｈｔ４受容体拮抗剤の使用
Fahr The treatment of cardiac irregularities
JP2015512919A (ja) 塩酸レルカニジピンおよびロサルタンカリウム配合剤およびその調製法
US20210128596A1 (en) Compositions and methods for treating septic cardiomyopathy
RU2267319C2 (ru) Фармацевтическая композиция и способ лечения синдрома хронической усталости с ее использованием
CA3125893C (en) Low dose pridopidine for parkinson's disease and other diseases associated with parkinsonism
Meloto et al. Dental practice implications of systemic diseases affecting the elderly: a literature review
RU2552330C1 (ru) Поликомпонентный мелатонинсодержащий препарат для регенерации тканей ротовой полости и способ его получения
JP6676329B2 (ja) 口腔粘膜投与用の唾液分泌促進用医薬組成物
FR2845916A1 (fr) Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
KR102902972B1 (ko) Iv형 콜라겐 질환의 치료를 위한 비페닐 설폰아미드 화합물
FR3081329A1 (fr) Medicament pour le traitement de troubles d’une fonction d’organe ou de tissu et de maladies accompagnees par de tels troubles, et son procede d’obtention

Legal Events

Date Code Title Description
MKEX Expiry